CEO Pernilla Sandwall presents the company at Swiss Nordic Bio 30 March
The conference will take place in Zurich on March 30, 2023 . Pernilla will present the company and the drug candidate Foxy-5, which aims to prevent the incidence of metastases. Pernilla will also talk about the interesting observations made in connection with the ongoing phase 2 study and the implications for the continuation of the study. The study is conducted on patients affected by colon cancer. Swiss Nordic Bio is a high-level partnering and investor conference that gathers life science professionals from Switzerland and the